FDA kicks off GDUFA III reauthorization process
In a public meeting held via webcast, officials of the FDA kicked off the process for reauthorizing the Generic Drug User Fee Amendments (GDUFA). The …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
